American Society of Clinical Oncology (ASCO)
ASCO Education
ASCO Education: By the Book delivers in-depth discussions with the editors and authors behind the ASCO Educational Book. Hear about key topics from ASCO meetings education sessions, perspectives on the state of the science, and deep dives into the complex approaches shaping modern oncology practice.
Author
American Society of Clinical Oncology (ASCO)
Category
Podcast website
Latest episode
Jun 8, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Annual Meeting 2019 - Contrasting Cases: Molecular Profiling in Breast Cancer 22.05.2019 12:01
Komal Jhaveri, MD, FACP, is a breast medical oncologist with dual appointments in the breast medicine and early drug development services at Memorial Sloan Kettering Center in New York. In this special Annual Meeting 2019 episode, Dr. Jhaveri discusses two patient cases that relate to adjuvant treatment for breast cancer. Click here to visit ASCO's Annual Meeting website to learn more about the ed...
ASCO Guidelines: Safe Handling of Hazardous Drugs 24.04.2019 10:26
An interview with Dr. Paul Celano from the greater Baltimore Medical Center, lead author on "Safe Handling of Hazardous Drugs: ASCO Standards." TRANSCRIPT The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions...
Contrasting Cases: Cancer Prevention 10.04.2019 6:21
Dr. Noelle LoConte, associate professor of medicine at the University of Wisconsin, presents two patient cases regarding cancer prevention. TRANSCRIPT Hello. My name is Noelle LoConte. I am a physician and associate professor at the University of Wisconsin Carbone Cancer Center in Madison. I am a GI medical oncologist in my clinical practice, and also the principal investigator of my state's Compr...
ASCO Guidelines: Treatment of Multiple Myeloma 03.04.2019 7:24
TRANSCRIPT The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endors...
ASCO Guidelines: Anticonvulsant Prophylaxis and Steroid Use in Adults with Metastatic Brain Tumors Endorsement 27.03.2019 6:24
TRANSCRIPT The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care, and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endor...
ASCO Guidelines: Adjuvant Therapy for Resected Biliary Tract Cancer 20.03.2019 8:59
TRANSCRIPT The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endors...
Self-Evaluation: Chemotherapy Dosing for Patients with Morbid Obesity 13.03.2019 6:41
Wendy Vogel is a Nurse Practitioner and President of APSHO, the Advanced Practitioner Society for Hematology and Oncology. In this week's episode, she presents a self-evaluation question about the correct chemotherapy treatment of obese patients and provides an explanation of the correct choice.
Contrasting Cases: TAILORx- Chemotherapy or no? 06.03.2019 6:30
Dr. Sparano is Professor of Medicine & Obstetrics, Gynecology, and Women's Health at the Albert Einstein College of Medicine, Associate Chairman for Clinical Research in the Department of Oncology at Montefiore Medical Center, and Associate Director for Clinical Research at the Albert Einstein Cancer Center. He also serves as Vice Chair of the ECOG-ACRIN Research Group and Vice Chair of the AIDS M...
Self-Evaluation: Soft-Tissue Sarcomas-Epidemiology 27.02.2019 4:06
Dr. Arun Singh, Co-Clinical Director of UCLA Sarcoma Clinic and Assistant Professor of Hematology and Oncology at UCLA, presents a self-assessment question from an ASCO University course focusing on the treatment of non-small cell lung cancers.
ASCO Guidelines: Adjuvant Endocrine Therapy for Women with Hormone Receptor Positive Breast Cancer Guideline 20.02.2019 12:25
TRANSCRIPT The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endors...
Contrasting Cases: Nephrectomy 13.02.2019 7:18
Dr. Daniel George is Professor of Medicine and Surgery, Director of GU Oncology for the Duke Cancer Institute, and Co-Chair of the DCI Center for Prostate and Urologic Cancers. Dr George's primary areas of interest are in drug development and optimizing care for patients with GU cancers, particularly prostate and kidney cancers. In this week's episode, Dr. George presents two contrasting cases wit...
Recent Approvals: Larotrectinib for the Treatment of Advanced Solid Tumors Containing NTRK Gene Fusion 06.02.2019 6:55
Dr. Yosef Landman is a graduate of the Sackler School of Medicine, Tel Aviv University. He is currently a medical oncology resident at Davidoff Cancer Center, Rabin Medical Center in Petach Tiqva, Israel. In today's episode, he discusses the recent approval of larotrectinib for tumor-agnostic treatment of advanced solid tumors containing NTRK gene fusion. Dr. Landman, a co-author on the journal pa...
Recent Approvals: Duvelisib for Adult Patients with Relapsed or Refractory CLL or SLL 30.01.2019 4:34
Dr. Ian Flinn, Medical Oncologist specializing in hematologic malignancies at Tennessee Oncology, discusses the recent FDA approval of duvelisib for adult patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). If you enjoyed this podcast, make sure to subscribe for more weekly education content from ASCO University. We truly value your feedback...
ASCO Guidelines: Evaluating Susceptibility to Pancreatic Cancer PCO 16.01.2019 6:34
If you enjoyed this podcast, make sure to subscribe for more weekly education content from ASCO University. We truly value your feedback and suggestions, so please take a minute to leave a review. If you are an oncology professional and interested in contributing to the ASCO University Weekly Podcast, email ascou@asco.org for more information. TRANSCRIPT The purpose of this podcast is to educate...
ASCO Guidelines: Hypofractionated Radiation Therapy for Localized Prostate Cancer Guideline 09.01.2019 16:09
If you enjoyed this podcast, make sure to subscribe for more weekly education content from ASCO University. We truly value your feedback and suggestions, so please take a minute to leave a review. If you are an oncology professional and interested in contributing to the ASCO University Weekly Podcast, email ascou@asco.org for more information. TRANSCRIPT The purpose of this podcast is to educate...
Recent Approvals: Cemiplimab Approval for Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma 02.01.2019 5:38
Dr. Axel Hauschild, professor of dermatology and head of the dermato-oncology department at the University Hospital of Kiel in Germany, discusses the recent FDA approval of cemiplimab, a PD-1 antibody treatment for patients with metastatic or locally advanced cutaneous squamous cell carcinomas. If you enjoyed this podcast, make sure to subscribe for more weekly education content from ASCO Universi...
ASCO Guidelines: Initial Diagnostic Workup of Acute Leukemia Guideline 19.12.2018 12:40
If you enjoyed this podcast, make sure to subscribe for more weekly education content from ASCO University. We truly value your feedback and suggestions, so please take a moment to leave a review. If you are an oncology professional and interested in contributing to the ASCO University Weekly Podcast, email ascou@asco.org for more information. TRANSCRIPT The purpose of this podcast is to educate...
New Drugs: Ivosidenib for Relapsed or Refractory Acute Myeloid Leukemia with Susceptible IDH1 Mutation 12.12.2018 4:55
In this week's episode, Dr. Danielle Shafer, Medical Director of the Clinical Trials Office at Massey Cancer Center at Virginia Commonwealth University, explores the recent FDA approval of ivosidenib for the treatment of relapsed or refractory acute myeloid leukemia. Dr. Shafer's primary clinical focus is leukemia & lymphoma in adult patients. Her research focus is limited to the same population,...
Self-Assessment: Predictive and Prognostic Rule of Pathological Complete Response in Breast Cancer Treatment 05.12.2018 4:31
Dr. Shaheenah Dawood is the Head of Medical Oncology and the Head of the Breast Cancer Program at Dubai Hospital in the United Arab Emirates. Dr. Dawood completed her M.B.B.Ch at Dubai Medical College in 1998 and a Master of Public Health degree at the Harvard School of Public Health, Boston, USA in 2008. Her postgraduate medical training programs include a Fellowship at McGill University in Canad...
Recent Drug Approvals: Lenvatinib Treatment of Unresectable Hepatocellular Carcinoma (HCC) 28.11.2018 5:09
This week's host, Dr. Thomas Karasic, is an assistant professor at University of Pennsylvania specializing in the treatment of gastrointestinal malignancies. In this episode, Dr. Karasic discusses the recent FDA approval of lenvantinib for patients with unresectable hepatocellular carcinoma. If you enjoyed this podcast, make sure to subscribe for more weekly education content from ASCO University....
Self-Evaluation: Multiple Myeloma and Plasma Cell Dyscrasias- MGUS 14.11.2018 4:08
If you enjoyed this podcast, make sure to subscribe for more weekly education content from ASCO University. We truly value your feedback and suggestions, so please take a minute to leave a review. If you are an oncology professional and interested in contributing to the ASCO University Weekly Podcast, email ascou@asco.org for more information. TRANSCRIPT Welcome to the Self-Evaluation episode of t...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.